LytM was determined to

be an early exponential-phase protein Navitoclax clinical trial and the expression of lytM was determined to be downregulated by Agr. This study, however, raises questions about the physiological role of this protein as an autolysin and suggests that the significance of this protein should be investigated beyond its role as an autolysin. The bacterial strains and plasmid constructs used in this study are shown in Table 1. Staphylococcus aureus and Escherichia coli cells were routinely grown aerobically at 37 °C in tryptic soy broth/agar (TSB; Beckton Dickinson) and Luria–Bertani broth/agar (LB; Fisher), respectively. Broth cultures were grown in a shaking incubator (220 r.p.m.) unless stated otherwise. When needed, ampicillin (50 μg mL−1), tetracycline (10 μg mL−1), erythromycin (10 μg mL−1) and chloramphenicol (10 μg mL−1) were added to the bacterial growth medium. Plasmid DNA was isolated using the Qiaprep kit (Qiagen Inc.); chromosomal DNA was isolated using the DNAzol kit (Molecular Research Center) from lysostaphin (Sigma)-treated S. aureus cells as per the manufacturer’s instructions. All restriction and modification enzymes were purchased from Promega. DNA manipulations were carried out using standard procedures. PCR was performed using the PTC-200 Peltier Thermal Cycler (MJ Research). Oligonucleotide

primers (Table 2) were obtained from Sigma Genosys. For this study, the lytM nucleotide sequence was obtained from the http://www.ncbi.nlm.nih.gov/sites/entrez?db=genome&cmd=Retrieve&dopt=Overview&list_uids=610 database, which suggests an additional 18 nucleotides at Alpelisib ic50 the 5′-end to be part of the lytM gene compared with what has been suggested by others (Ramadurai & Jayaswal, 1997; Ramadurai et al., 1999). To create a lytM deletion mutant, a set of two primers, P1 and P2, was used to amplify a 1083-bp DNA fragment using genomic DNA extracted from S. aureus strain SH1000 as a template. This amplicon represented 192 nt of the 5′-end and additional DNA upstream

of the lytM gene. Primers P3 and P4 were tuclazepam used to amplify an 834-bp DNA fragment that represented 68 nt of the 3′-end of the lytM gene and an additional downstream region. These two fragments were cloned individually into plasmid pGEMT (Promega) and subsequently ligated together in plasmid pTZ18R (Mead et al., 1986) resulting in the construct pTZ–lytM that simultaneously generated a unique BamH1 restriction site between the ligated fragments. A 2.2 kb tetracycline resistance cassette was subsequently inserted at this BamH1 site, yielding the pTZ–lytM–tetM construct, which was used as a suicidal construct to transform S. aureus RN4220 cells by electroporation (Schenk & Laddaga, 1992). Selection of the transformants on tetracycline plates led to the integration of the entire construct into the chromosome. Phage 80α was propagated on these transformants and used to resolve the mutation in the lytM gene in the S.